ESC 365 - Ventricular tachycardia ablation improves long-term outcome - pro

EHRA Premium Access

Ventricular tachycardia ablation improves long-term outcome - pro

Session: Controversies in management of ventricular arrhythmias

Topic: Treatment

Speaker: Professor G. Hindricks (Berlin, DE)

Event: EHRA 2021

Congress Presentation

Add to my library

About the speaker

Professor Gerhard Hindricks

Charite University Hospital, Berlin (Germany)

94 presentations

33 followers

5 more presentations in this session

Preferred first-line therapy for recurrent ICD shocks: drugs or ablation? - drugs are preferred

Speaker: Professor J. Healey (Hamilton, CA)

Preferred first-line therapy for recurrent ICD shocks: drugs or ablation? - ablation is preferred

Speaker: Professor K. Kuck (Luebeck, DE)

Preferred first-line therapy for recurrent ICD shocks: drugs or ablation? – rebuttal & discussion

Ventricular tachycardia ablation improves long-term outcome - con

Speaker: Professor C. de Chillou (Nancy, FR)

Ventricular tachycardia ablation improves long-term outcome - rebuttal & discussion

Access the full session

Controversies in management of ventricular arrhythmias

Speakers: Professor G. Hindricks, Professor J. Healey, Professor K. Kuck, Professor C. de Chillou

About the event

EHRA 2021

23 April - 25 April 2021

Sessions Presentations

Congress

ESC 365 is supported by

bristol-myers-squibb

Explore sponsored resources

novartis

Explore sponsored resources